Delivery Order 36F79724D0176-36C25926F0310
Award Date 9/3/26
Potential Completion Date 10/19/26
Potential Value $385K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Horsham, PA 19044, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 19 issued a delivery order to Janssen Biotech Inc. on July 31, 2026, with a ceiling value of $384,718.69 for emergency pharmacy supply of CARVYKTI under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The FSS-61-IB is a GSA-administered multiple-award federal supply schedule for pharmaceutical products. Place of performance is Horsham, PA. The order carries a firm fixed-price structure with an ultimate completion date of August 31, 2026.
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 19, awarded a $351,987.69 firm fixed-price delivery order to Janssen Biotech Inc. (doing business as Centocor Ortho Biotech Inc.) on December 16, 2025, for pharmacy purchases to be performed in Horsham, PA. This delivery order, with an ultimate completion date of January 16, 2026, carries no set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Janssen Biotech, a...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,046 delivery order to Janssen Biotech, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for BALVERSA 4MG and will be fulfilled from July 18-20, 2023 with performance taking place in Carrollton, Texas. Janssen Biotech will provide the specified oncology drug to VA-VHA under a firm fixed price arrangement. As one of the largest health care...
- Janssen Products LP was awarded a $22,685 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23. The firm fixed price order is for patient medication and will be fulfilled by Janssen from its place of performance in Horsham, Pennsylvania by September 30, 2022. No set-aside provisions were applied to this order placed under GSA Schedule master contract FSS-61-IB....
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $15,090.62 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for the drug erdafitinib. The firm fixed price order is for delivery to a location in Horsham, Pennsylvania, with completion by September 30, 2021. No set aside designation was used for this order to support VHA programs. Janssen Biotech will provide...
- <p>Veterans Integrated Service Network 5 issued a $31,040.96 delivery order to Ucb, Inc. on August 6, 2026, for injectable pharmaceutical supply under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).</p> <p>The order is for an injectable drug for a veteran, with ultimate completion on September 30, 2026. Place of performance is Pittsburgh, PA. The order carries firm fixed-price pricing with no set-aside designation.</p>
- Janssen Biotech, Inc. was awarded a $15,754.46 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the drug BALVERSA 4MG and has a period of performance through December 7, 2022. No set-aside provisions were applied to this award to supply prescription medications in support of healthcare...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,046 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Janssen Biotech, Inc. to provide BALVERSA 4MG. The place of performance is Carrollton, Texas. The period of performance is September 13-14, 2023. This delivery order supports the VA's mission to provide healthcare services to veterans through its Veterans Integrated Service Network...
- Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., has been awarded a $17,642.95 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to provide BALVERSA 4 MG. The delivery order was placed against Janssen's multiple award GSA Schedule Pharmaceuticals and Drugs contract, also known as FSS-61-IB, which has no set-aside designation and expires in March 2024. As a manufacturer of pharmaceutical...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 5, awarded a $20,295.20 firm fixed-price delivery order to Janssen Biotech Inc. (doing business as Centocor Ortho Biotech Inc.) for BALVERSA 4 MG, a specialized oncology medication used in cancer treatment. This delivery order was issued on March 20, 2026, with an ultimate completion date of March 24, 2026, and will be performed in Carrollton, Texas. The award carries no set-aside designation, reflecting Janssen...